Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (341-350 of 682) with videos related to

Pageof 69
Sort By:
Clinical Pharmacokinetics|December 31, 2016
Caspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or HaemodiafiltrationClaire Roger, Steven C Wallis, Laurent Muller, et al.
Infectious Diseases (London, England)|March 11, 2015
Even high-dose extended infusions may not yield desired concentrations of β-lactams: the value of therapeutic drug monitoringMenino Osbert Cotta, Belinda Gowen, Natasha Truloff, et al.
Anaesthesia, Critical Care & Pain Medicine|December 25, 2018
French legal approach to clinical researchElisabeth Toulouse, Christophe Masseguin, Brigitte Lafont, et al.
International Journal of Antimicrobial Agents|July 30, 2023
In vitro susceptibility testing of imipenem-relebactam and tedizolid against 102 Mycobacterium abscessus isolatesAndrew Burke, Robyn Carter, Carla Tolson, et al.
The Journal of Antimicrobial Chemotherapy|February 25, 2022
Oral fosfomycin activity against Klebsiella pneumoniae in a dynamic bladder infection in vitro modelIain J Abbott, Elke van Gorp, Kelly L Wyres, et al.
Antimicrobial Agents and Chemotherapy|January 8, 2020
Oral Fosfomycin Efficacy with Variable Urinary Exposures following Single and Multiple Doses against <i>Enterobacterales</i>: the Importance of Heteroresistance for Growth OutcomeIain J Abbott, Elke van Gorp, Rixt A Wijma, et al.
Clinical Pharmacokinetics|December 21, 2021
Caspofungin Population Pharmacokinetic Analysis in Plasma and Peritoneal Fluid in Septic Patients with Intra-Abdominal Infections: A Prospective Cohort StudyNicolas Garbez, Litaty C Mbatchi, Steven C Wallis, et al.
International Journal of Antimicrobial Agents|November 5, 2016
Optimising meropenem dosing in critically ill Australian Indigenous patients with severe sepsisDanny Tsai, Penelope Stewart, Rajendra Goud, et al.
The Journal of Antimicrobial Chemotherapy|October 23, 2014
Are interstitial fluid concentrations of meropenem equivalent to plasma concentrations in critically ill patients receiving continuous renal replacement therapy?Julie M Varghese, Paul Jarrett, Steven C Wallis, et al.
Antimicrobial Agents and Chemotherapy|October 14, 2016
Pharmacokinetics of Piperacillin in Critically Ill Australian Indigenous Patients with Severe SepsisDanny Tsai, Penelope Stewart, Rajendra Goud, et al.
Pageof 69

Showing results (341-350 of 682) with videos related to

Sort By:
Pageof 69
Clinical Pharmacokinetics|December 31, 2016
Caspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or HaemodiafiltrationClaire Roger, Steven C Wallis, Laurent Muller, et al.
Infectious Diseases (London, England)|March 11, 2015
Even high-dose extended infusions may not yield desired concentrations of β-lactams: the value of therapeutic drug monitoringMenino Osbert Cotta, Belinda Gowen, Natasha Truloff, et al.
Anaesthesia, Critical Care & Pain Medicine|December 25, 2018
French legal approach to clinical researchElisabeth Toulouse, Christophe Masseguin, Brigitte Lafont, et al.
International Journal of Antimicrobial Agents|July 30, 2023
In vitro susceptibility testing of imipenem-relebactam and tedizolid against 102 Mycobacterium abscessus isolatesAndrew Burke, Robyn Carter, Carla Tolson, et al.
The Journal of Antimicrobial Chemotherapy|February 25, 2022
Oral fosfomycin activity against Klebsiella pneumoniae in a dynamic bladder infection in vitro modelIain J Abbott, Elke van Gorp, Kelly L Wyres, et al.
Antimicrobial Agents and Chemotherapy|January 8, 2020
Oral Fosfomycin Efficacy with Variable Urinary Exposures following Single and Multiple Doses against <i>Enterobacterales</i>: the Importance of Heteroresistance for Growth OutcomeIain J Abbott, Elke van Gorp, Rixt A Wijma, et al.
Clinical Pharmacokinetics|December 21, 2021
Caspofungin Population Pharmacokinetic Analysis in Plasma and Peritoneal Fluid in Septic Patients with Intra-Abdominal Infections: A Prospective Cohort StudyNicolas Garbez, Litaty C Mbatchi, Steven C Wallis, et al.
International Journal of Antimicrobial Agents|November 5, 2016
Optimising meropenem dosing in critically ill Australian Indigenous patients with severe sepsisDanny Tsai, Penelope Stewart, Rajendra Goud, et al.
The Journal of Antimicrobial Chemotherapy|October 23, 2014
Are interstitial fluid concentrations of meropenem equivalent to plasma concentrations in critically ill patients receiving continuous renal replacement therapy?Julie M Varghese, Paul Jarrett, Steven C Wallis, et al.
Antimicrobial Agents and Chemotherapy|October 14, 2016
Pharmacokinetics of Piperacillin in Critically Ill Australian Indigenous Patients with Severe SepsisDanny Tsai, Penelope Stewart, Rajendra Goud, et al.
Pageof 69